News
-
-
-
PRESS RELEASE
Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization
Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025 -
-
PRESS RELEASE
Communiqué de presse : La thérapie SAR446268 de Sanofi obtient son admission dans la procédure accélérée américaine pour le traitement de la dystrophie myotonique non congénitale de type 1
Sanofi's SAR446268 therapy granted fast track designation by US FDA for treating non-congenital myotonic dystrophy type 1. Innovative gene therapy aims to address unmet medical need -
PRESS RELEASE
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
Sanofi's SAR446268 granted US fast track designation for non-congenital myotonic dystrophy type 1. AAV gene therapy aims to silence DMPK expression, addressing symptoms and filling unmet need -
-
-
PRESS RELEASE
La campagne 'Thai’d Up This Summer' de L'Office du Tourisme de Thaïlande (TAT) éveille le désir de voyage mondial avec énergie jeunesse et richesse culturelle
L'Office du Tourisme de Thaïlande clôture sa campagne 'Thai'd Up This Summer' mettant en lumière la culture, la beauté naturelle et la créativité de la Thaïlande à travers des voyages durables. La Thaïlande devient une émotion, une histoire, une expérience partagée pour les voyageurs européens -
PRESS RELEASE
The Tourism Authority of Thailand (TAT)’s 'Thai’d Up This Summer' Campaign Sparks Global Wanderlust with Youthful Energy and Cultural Depth
The Tourism Authority of Thailand concludes successful 'Thai'd Up This Summer' campaign, showcasing cultural richness, natural beauty, and creative spirit to European travelers
